Related by context. Frequent words. (Click for all words.) 79 refractory chronic lymphocytic 78 forodesine 76 multi kinase inhibitor 76 Panzem R 73 CYC# 73 proteasome inhibitor 73 Factor VIIa 73 polymerase inhibitor 73 liposomal formulation 73 orally bioavailable 73 ALN TTR# 72 humanized anti 71 mTOR inhibitor 71 Aurora kinase 71 Epratuzumab 71 MEK inhibitor 71 Voreloxin 71 Metastatic Melanoma 71 phase IIb clinical 71 anticancer compound 70 targeting CD# 70 Initiate Phase 70 R sorafenib tablets 70 KRN# 70 sodium Injection 70 HCV protease inhibitor 70 Traficet EN 70 selective inhibitor 70 Presents Positive 69 Mipomersen 69 ONX 69 injectable formulation 69 cutaneous T cell 69 EZN 69 registrational trial 69 HGS ETR1 69 immunomodulator 69 subcutaneous formulation 69 VALSTAR 69 relapsed refractory multiple myeloma 69 Drug Candidate 69 EOquin 69 relapsed multiple myeloma 69 II Clinical Trial 69 Proxinium TM 69 Irinotecan 69 Tesetaxel 69 eniluracil 69 pseudobulbar affect PBA 68 metastatic castration resistant 68 Phase IIb trials 68 luteinizing hormone releasing 68 Nexavar ® 68 non alcoholic steatohepatitis 68 ganetespib 68 Belimumab 68 oncolytic 68 PEG SN# 68 vascular disrupting agent 68 PSN# [002] 68 MKC# 68 TLR9 agonist 68 CORT # 68 lymphoma CTCL 68 hypoxia inducible factor 68 selectively inhibits 68 KNS # 68 elotuzumab 68 Pivotal Phase III 68 SARMs 68 factor G CSF 68 Amrubicin 68 OncoVEX GM CSF 68 Completes Enrollment 68 romidepsin 68 Onalta 68 angiogenesis inhibitor 68 metastatic hormone refractory 68 Hepatitis C Virus HCV 68 Lenalidomide 68 Diabetic Macular Edema 68 Application MAA 67 anti TNF alpha 67 CCX# 67 Zolinza 67 DDP# 67 ApoB SNALP 67 phase IIa clinical 67 VQD 67 advanced carcinoid 67 Ofatumumab 67 fumarate 67 Recombinant Human 67 SAR# [004] 67 Application BLA 67 Bortezomib 67 epothilone 67 hematological malignancies 67 Guanilib 67 Entereg R 67 Pivotal Phase